Hydroxamic acid derivatives

The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.

Saved in:
Bibliographic Details
Main Authors BAXTER ANDREW DOUGLAS, SHARPE ANDREW, DYKE HAZEL JOAN, HANNAH DUNCAN ROBERT
Format Patent
LanguageEnglish
Published 26.10.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.
Bibliography:Application Number: US20010858106